Study of AMX0114 for people with ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests an experimental drug called AMX0114 for people recently diagnosed with ALS. It is an early-phase trial to see if the drug is safe and how it affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with definite or probable ALS by an ALS specialist
- Your first ALS symptoms started less than 2 years ago
- You do not have a tracheostomy (breathing tube) or need permanent machine-assisted breathing
- Your blood tests for liver, kidney, and blood counts are within safe limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called PLL001 for people with ALS. It aims to see if the drug is safe and if it can slow the progression of the disease. You may be a good fit if you have been recently diagnosed and are still in the early stages of ALS.
This trial studies blood or other lab markers in people with ALS, including different ALS patterns, to better understand how the disease works and responds to treatment with edaravone. You may be helped by close monitoring, and the results may guide future ALS care.
This trial tests an experimental drug called MRG-001 for people with amyotrophic lateral sclerosis (ALS). It aims to see if the drug can help slow the progression of the disease.
This trial tests a new medicine, CB03-154, to see if it can help people with ALS. Researchers are comparing different doses to find the safest and most effective one.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
Hear when a new ALS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.